We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Phosphorus metabolism disorders in erythrocytes and lymphocytes among patients with inflammatory breast cancer, infiltrative stomach and colorectal cancer
Summary
Researchers examined phosphorus metabolism and energy dysfunction in erythrocytes and lymphocytes among 49 patients with inflammatory breast cancer, infiltrative stomach cancer, and colorectal cancer to identify prognostic markers. They found distinct phosphorus metabolism disorder patterns across cancer types, suggesting these metabolic disruptions as potential predictive factors for disease course and prognosis.
Energy and plastic potential dysfunction of erythrocytes and lymphocytes among people with inflammatory breast cancer, infiltrative stomach cancer, and infiltrative colon cancer is characterized by a more aggressive clinical course and poor prognosis. We explored the features of energy metabolism and phosphorus metabolism disorders in the erythrocytes and lymphocytes of patients with inflammatory breast cancer, infiltrative stomach cancer, and infiltrative colon cancer as a predicting factor in the course of the disease. 49 people were examined; the 1st group had infiltrative stomach cancer (n=17); the 2nd group had infiltrative colon cancer (n=11); the 3rd group had inflammatory breast cancer (n=21). Glycerol-3-phosphate dehydrogenase activity was 1.8 times reduced (p≤0.005), and the activity of glyceraldehyde-3-phosphate dehydrogenase in erythrocytes of patients with cancer at the main localization increased 2.5 times, compared with normal. Inflammatory breast cancer patients had a statistically significant decrease (p<0.005) in erythrocytes adenosine triphosphate content by an average of 56.5% compared with the normal ratio, and in cases of patients with gastric and colorectal cancer, a decrease of 67%. Excessive use of phosphorus for energy metabolism and adenosine triphosphate production destroys the balance of energetic and plastic potentials of erythrocytes and lymphocytes in inflammatory breast cancer, infiltrative stomach, and infiltrative colorectal cancers patients.
Sign in to start a discussion.
More Papers Like This
Role of dietary nutrients and metabolism in colorectal cancer.
This review examines how dietary nutrients including glucose, amino acids, lipids, vitamins, and prebiotics may influence colorectal cancer risk and progression. The study discusses metabolic interactions between tumor cells, the tumor microenvironment, and gut microbiota, suggesting that nutritional factors play a meaningful role in shaping these complex biological processes.
Tumour-infiltrating microplastics disrupt the JAK-STAT-microbiota axis to promote immunotherapy resistance in colorectal cancer
Researchers isolated microplastics from colorectal cancer tumor tissues and blood samples and examined their properties and effects on cancer progression. They found that tumor-infiltrating microplastics disrupted the JAK-STAT signaling pathway and altered gut microbiota composition, potentially reducing the effectiveness of immunotherapy. The study suggests that microplastic presence in tumors may be a factor worth investigating in cancer treatment outcomes.
Exploring the prognostic implications of PET microplastic degradation products in colorectal cancer: insights from an integrated computational analysis on glucocorticoid pathway–mediated mechanisms
This computational study investigated how PET microplastic degradation products affect colorectal cancer prognosis, identifying 43 genes linking ethylene glycol and terephthalic acid exposure to cancer pathogenesis via chronic inflammation mediated through TNF/IL-17 and glucocorticoid metabolic pathways.
Endoplasmic Reticulum Stress-related Classification for Prognosis Prediction in Hepatocellular Carcinoma
Researchers used gene expression data to create an endoplasmic reticulum stress-based classification system for predicting outcomes in liver cancer patients. The model identified patient subgroups with significantly different survival rates.
Early Predictor Tool of Disease Using Label-Free Liquid Biopsy-Based Platforms for Patient-Centric Healthcare
Algorithmic analysis of patient-derived cell clusters from liquid biopsy samples was combined with tumor models to develop an early disease prediction tool applicable across cancer types. The approach offers a label-free, non-invasive method for early cancer detection that could supplement or reduce reliance on conventional tissue biopsy.